A major factor in the progression to heart failure in humans is the inability of the adult heart to repair itself following injury. As a result, strategies to induce heart regeneration are of significant interest. Previously, our group demonstrated that, unlike the adult heart, the early postnatal mammalian heart is capable of regeneration following injury through proliferation of existing cardiomyocytes. We have shown that Meis1, a TALE family homeodomain protein, promotes postnatal withdrawal from cell cycle by activating expression of the cyclin dependent inhibitors p16 and p21. We, along with other investigators, have gone on to identify a diversity of additional signaling mechanisms that act to either permit or restrict proliferation (increased mechanical load, oxygenation, DNA damage response, etc.). This suggests that Meis1 does not work alone, but must act as part of a network of regulatory processes, although, the molecular mechanisms linking these processes are largely unknown. Moving forward, the goal of our current proposal is to integrate Meis1- dependent mechanisms with the wider postnatal signaling network by identifying Meis1 cofactors and regulators. Specifically, we will focus on defining the functional interaction of Meis1 with its cofactor Hoxb13 in the postnatal heart and the role played by the Ca2+-activated protein phosphatase calcineurin (CN) in regulating this interaction and its consequences. The postnatal increase in cardiac load is known to initiate a signaling cascade that leads to cardiomyocyte hypertrophy and increased contractility. Activation of CN provides fundamental signals that promote hypertrophic growth of cardiomyocytes. Our preliminary studies suggest that CN also works in conjunction with a Meis1/Hoxb13 complex to suppress proliferative growth. Thereby, postnatal activation of CN provides a signal that helps switch the mechanism of cardiac growth from hyperplastic to hypertrophic. We hypothesize that CN promotes postnatal arrest of cardiomyocyte cell cycle by mediating nuclear translocation of Meis1 and HoxB13. Our experiments are designed to (1) examine the role of Hoxb13 as a Meis1 co-factor, (2) define the mechanism of CN regulation of Meis1 and Hoxb13 function, and (3) test the ability of CN to control postnatal cell cycle and heart regeneration. These studies will provide fundamental insights into the nature of the coordinating link between the postnatal increase in cardiac load that drives hypertrophy, and suppression of the heart?s capacity for repair.

Public Health Relevance

Research in this proposal is aimed at understanding the mechanisms that control the regenerative capacity of cardiac muscle. Our long-term goal is to use this knowledge to increase repair of the human heart following damage such as occurs from a heart attack or during the normal process of aging.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Wong, Renee P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code